{"3299":{"name":"Chronic Kidney Disease","field":{"field_module_program":null}},"3308":{"name":"Complex Patients: Therapies that Can Reduce Mortality","field":{"field_module_program":null}},"3301":{"name":"Diabetes in Aboriginal Populations","field":{"field_module_program":null}},"3309":{"name":"Diabetes Management in the Presence of Glucocorticoids","field":{"field_module_program":null}},"3310":{"name":"Early Use of Insulin Therapy in T2D","field":{"field_module_program":null}},"3302":{"name":"Eating Disorders in Diabetes","field":{"field_module_program":null}},"3311":{"name":"Effects of Exercise & Hormones on Blood Glucose","field":{"field_module_program":null}},"3304":{"name":"Fasting with Diabetes","field":{"field_module_program":null}},"3305":{"name":"Foot Care in Persons with Diabetes","field":{"field_module_program":null}},"3306":{"name":"Hyperglycemic Emergencies and Sick Day Management","field":{"field_module_program":null}},"3307":{"name":"Mental Health and Diabetes","field":{"field_module_program":null}},"3329":{"name":"MODULE 1: REVIEW OF THE OF PSORIASIS AND NOVEL TREATMENT OPTIONS","field":{"field_module_program":["The Target is Clear"]}},"3330":{"name":"MODULE 2: CONSIDERATIONS FOR SCREENING, INITIATING AND MONITORING BIOLOGIC THERAPIES","field":{"field_module_program":["The Target is Clear"]}},"3331":{"name":"MODULE 3: PSORIASIS TREATMENT OPTIMIZATION","field":{"field_module_program":["The Target is Clear"]}},"3332":{"name":"MODULE 4: TOPICS OF SPECIAL INTEREST:INFLAMMATORY BOWEL DISEASE (IBD), DEPRESSION\/SUICIDALITY AND CANDIDIASIS","field":{"field_module_program":["The Target is Clear"]}},"3333":{"name":"MODULE 5: MANAGING SPECIAL SITUATIONS AND PATIENT POPULATIONS: HIV, TUBERCULOSIS (TB), HEPATITIS B & C, CHRONIC PERIODONTITIS AND THE USE OF BIOLOGICS IN PREGNANCY","field":{"field_module_program":["The Target is Clear"]}},"3312":{"name":"Shift Work, Driving Guidelines and Travel\/Time Zone Management","field":{"field_module_program":null}}}
